Abstract
Four successive generations of antigenic variants of influenza PR8-S virus, each derived from the previous one by serial passage in the lungs of mice immunized with the homologous agent, were compared with the original parent PR8-S virus with respect to their serological and immunological character. It was demonstrated by means of H.I., complement-fixation and in ovo-neutralization tests that the variants exhibited a progressively decreasing reactivity with the parent PR8-S antiserum while retaining the ability to elicit antibody to PR8-S influenza virus and to their respective predecessors. Accompanying these changes was a progressive reduction in antigenicity without any significant changes in pathogenicity for mice. Experimental evidence was presented which indicates that the serological changes observed with the variants are not related to the P-Q phenomenon. Antibody absorption tests showed that the variants share antigens with PR8-S virus but differ from it by the presence of specific antigenic components; these increase in quantity with each successive variant while the amount of related antigens shows a progressive decrease. The importance of evaluating the significance of antigenic changes of influenza viruses with active immunity tests was emphasized by the fact that PR8-S vaccine protected mice against fatal infection with lethal doses of the variant strains although the latter had a progressively decreasing serological reactivity with PR8-S antiserum. The inheritable character of the new antigenic properties of the variant strains was demonstrated by their persistence in the absence of thea selective environment following 18 to 24 serial intranasal passages with large inocula in normal mice and following limiting dilution passage in fertile eggs.
Full Text
The Full Text of this article is available as a PDF (633.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ARCHETTI I., HORSFALL F. L., Jr Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. J Exp Med. 1950 Nov 1;92(5):441–462. doi: 10.1084/jem.92.5.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FISET P., DEPOUX R. Serological behaviour of influenza viruses. II. Patterns of antigenic relationship. Bull World Health Organ. 1954;11(6):987–993. [PMC free article] [PubMed] [Google Scholar]
- Francis T., Salk J. E., Quilligan J. J. Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report. Am J Public Health Nations Health. 1947 Aug;37(8):1013–1016. doi: 10.2105/ajph.37.8.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GERBER P., LOOSLI C. G., HAMBRE D. Antigenic variants of influenza A virus, PR8 strain. I. Their development during serial passage in the lungs of partially immune mice. J Exp Med. 1955 Jun 1;101(6):627–638. doi: 10.1084/jem.101.6.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HILLEMAN M. R., HORSFALL F. L., Jr Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralization and hemagglutination-inhibition. J Immunol. 1952 Sep;69(3):343–356. [PubMed] [Google Scholar]
- ISAACS A., GLEDHILL A. W., ANDREWES C. H. Influenza A viruses; laboratory studies, with special reference to European outbreak of 1950-1. Bull World Health Organ. 1952;6(3):287–315. [PMC free article] [PubMed] [Google Scholar]
- LENNETTE E. H., CLARK W. H., DEAN B. H. Sheep and goats in the epidemiology of Q fever in northern California. Am J Trop Med Hyg. 1949 Jul;29(4):527–541. doi: 10.4269/ajtmh.1949.s1-29.527. [DOI] [PubMed] [Google Scholar]
- Robertson O. H., Puck T. T., Lemon H. F., Loosli C. G. THE LETHAL EFFECT OF TRIETHYLENE GLYCOL VAPOR ON AIR-BORNE BACTERIA AND INFLUENZA VIRUS. Science. 1943 Feb 5;97(2510):142–144. doi: 10.1126/science.97.2510.142. [DOI] [PubMed] [Google Scholar]
- TYRRELL D. A. J., HORSFALL F. L., Jr A procedure which eliminates nonspecific inhibitor from human serum but does not affect specific antibodies against influenza viruses. J Immunol. 1952 Nov;69(5):563–574. [PubMed] [Google Scholar]
- WALKER D. L., HORSFALL F. L., Jr Lack of identity in neutralizing and hemagglutination-inhibiting antibodies against influenza viruses. J Exp Med. 1950 Jan 1;91(1):65–86. doi: 10.1084/jem.91.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WOOLRIDGE R. L., DEMEIO J. L., WHITESIDE J. E., SEAL J. R. Epidemic influenza B and C in navy recruits, 1953-1954. I. Antigenic studies on influenza virus, type B. Proc Soc Exp Biol Med. 1955 Mar;88(3):430–435. doi: 10.3181/00379727-88-21609. [DOI] [PubMed] [Google Scholar]
- Wiener M., Henle W., Henle G. STUDIES ON THE COMPLEMENT FIXATION ANTIGENS OF INFLUENZA VIRUSES TYPES A AND B. J Exp Med. 1946 Mar 31;83(4):259–279. [PMC free article] [PubMed] [Google Scholar]